In Re N.A.D. Inc., Also Trading as North American Drager

754 F.2d 996, 224 U.S.P.Q. (BNA) 969, 1985 U.S. App. LEXIS 14712
CourtCourt of Appeals for the Federal Circuit
DecidedFebruary 14, 1985
DocketAppeal 84-1215
StatusPublished
Cited by5 cases

This text of 754 F.2d 996 (In Re N.A.D. Inc., Also Trading as North American Drager) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re N.A.D. Inc., Also Trading as North American Drager, 754 F.2d 996, 224 U.S.P.Q. (BNA) 969, 1985 U.S. App. LEXIS 14712 (Fed. Cir. 1985).

Opinion

RICH, Circuit Judge.

This appeal is from the February 29, 1984 decision of the United States Patent and Trademark Office (PTO) Trademark Trial and Appeal Board (board), 221 USPQ 1115, affirming the PTO Trademark Attorney’s refusal to register a trademark by reason of 15 U.S.C. § 1052(d), section 2(d) of the Trademark Act of 1946. We reverse.

The mark sought to be registered is NARKOMED. The goods named in the application are “anesthesia machines for use in surgery.” Application to register was filed May 7, 1980, alleging first use April 3, 1972. The rejection is predicated on two prior registrations: (1) Reg. No. 982,657, April 23, 1974, or NARCO MEDICAL SERVICES for “rental and leasing of hospital and surgical equipment and consultation services relating to the operation of such equipment.” This service mark registration issued to Air-Shields, Inc. and on April 26,1978 was assigned to Narco Scientific Industries, Inc. (2) Reg. No. 1,036,695, March 30, 1976, of NARCO and design (see board opinion for illustration) for a long list of specialized medical equipment including, as most relevant here, “apparatus for administration of anesthesia.” This registration issued to Narco Scientific Industries, Inc. which changed its name to Narco Scientific, Inc. The board opinion contains the full list of goods named in the registration.

The examining attorney and the board were both of the view that registration must be refused under § 2(d) 1 because, in *998 their commonly held opinions, on which they had no doubts, “confusion between the applicant’s mark and the cited registered marks is likely,” to quote from the board’s opinion. Applicant’s arguments relying on differences in the marks, sophistication of purchasers of the equipment or services, and the high prices thereof were summarily dismissed as “not persuasive.” As to registration (2), supra, there is no question that identical goods are named by both applicant and registrant. As to the services in registration (1), they are clearly closely related to applicant’s goods, all being in the medical equipment field.

As this court and its predecessor, the Court of Customs and Patent Appeals, have often said, each likelihood-of-confusion trademark case must be determined on its own facts. Curtice-Burns, Inc. v. Northwest Sanitation Products, Inc., 530 F.2d 1396, 1399, 189 USPQ 138, 141 (CCPA 1976). Beside that, however, the salient feature of this case is an argument, which has several times been fully dealt with in earlier cases, based on agreements between appellant and the owner of the prior registrations relied on to support the rejection containing a consent to the use and registration of NARKOMED by appellant.

The agreements containing the consent to use and register came about as follows. Applicant-appellant, N.A.D., Inc., which also does business as North American Drager, is a Pennsylvania corporation the majority of the stock of which is owned by Draegerwerk AG, of Luebeck, Federal Republic of Germany. Draegerwerk AG brought cancellation proceedings to cancel the two reference registrations herein, now both owned by Narco Scientific, Inc. These cancellations were inter parties proceedings extending over several years in which competitors in a relatively restricted field were involved, the disputes involving many marks other than NARKOMED. By written settlement agreements, Draegerwerk AG and N.A.D. undertook to abandon certain pending trademark registration applications and to discontinue the use of four different NARKO- marks, provision being made for a phasing-out period. Money changed hands. In the course of it all, the other party, Narco Scientific Inc., owner of the two references, expressly acknowledged N.A.D.’s right “to the use and registration of the trademark NARKOMED ... for use in the sale of hospital and medical equipment.” The first agreement so providing was in November 1975 and the second one, reaffirming that provision, was in September 1979. While we are uninformed as to all the details of the disputes and negotiations, these competitors clearly thought out their commercial interests with care. We think it highly unlikely that they would have deliberately created a situation in which the sources of their respective products would be confused by their customers. As was said by our predecessor court in In re E.I. duPont de Nemours & Co., 476 F.2d 1357, 1362, 177 USPQ 563, 568 (CCPA 1973), “It can be safely taken as fundamental that reputable businessmen-users of valuable trademarks have no interest in causing public confusion.”

The Examining Attorney, while citing DuPont and saying that “great weight is to be accorded consent agrees ments,” interpreted that case, erroneously, as allowing registration only “where the goods of the respective parties were disparate, and the markets and trade channels were different.” She held that “Notwithstanding an agreement between the parties, the likelihood of confusion cannot be avoided.” She concluded that “refusal of registration is appropriate notwithstanding the consent agreement. Drums Ltd. v. Drums Unlimited, 210 USPQ 222 (TTAB, *999 1981).” 2 In affirming, the board refused to give any weight to the contractual consent to use and to register, saying:

An appropriate consent agreement can tip the scales in favor of an applicant if there is doubt as to the likelihood of confusion. * * * In light of the fact that no doubt exists [in the board’s mind] and the parties have failed to specify how customer confusion can be avoided, we do not find that the consent agreement is an appropriate basis upon which to base registration. [Emphasis ours.]

Earlier in its opinion the board had said:

As we stated in In re Loew’s Theatres, Inc., 197 USPQ 183 (TTAB 1977), to be persuasive that confusion is not likely, the agreement must show that there are differences in the goods and that the registrant and the applicant can and will remain clear of each other’s marketing and trade channels so that there is no real likelihood that customers will be confused.

We note that the board cited no precedent other than its own opinion in Loew’s for these novel and stringent requirements. An examination of the Loew’s opinion shows, moreover, that it did not actually lay down any such definite rule but rather said that “the teaching of the DuPont and United cases is” that such an agreement as the board has here prescribed “may lead to a conclusion that there is no likelihood of confusion, mistake or deception of purchasers.” The reference to United is to In re United Oil Manufacturing Co., 508 F.2d 1341,184 USPQ 490 (CCPA 1975).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
754 F.2d 996, 224 U.S.P.Q. (BNA) 969, 1985 U.S. App. LEXIS 14712, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-nad-inc-also-trading-as-north-american-drager-cafc-1985.